419 related articles for article (PubMed ID: 26600217)
41. Mouse models of acute and chronic hepacivirus infection.
Billerbeck E; Wolfisberg R; Fahnøe U; Xiao JW; Quirk C; Luna JM; Cullen JM; Hartlage AS; Chiriboga L; Ghoshal K; Lipkin WI; Bukh J; Scheel TKH; Kapoor A; Rice CM
Science; 2017 Jul; 357(6347):204-208. PubMed ID: 28706073
[TBL] [Abstract][Full Text] [Related]
42. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
Gonzalez VD; Landay AL; Sandberg JK
Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
[TBL] [Abstract][Full Text] [Related]
43. Role of regulatory T-cells during hepatitis C infection: From the acute phase to post-transplantation recurrence.
Barjon C; Dahlqvist G; Calmus Y; Conti F
Dig Liver Dis; 2015 Nov; 47(11):913-7. PubMed ID: 26216068
[TBL] [Abstract][Full Text] [Related]
44. IMMUNOGENETIC FACTORS INFLUENCING CLINICAL COURSE OF HCV INFECTION (REVIEW).
Kamkamidze G; Butsashvili M; Gendzekhadze K
Georgian Med News; 2016 Sep; (258):84-89. PubMed ID: 27770537
[TBL] [Abstract][Full Text] [Related]
45. Innate and Adaptive Immune Responses in Chronic HCV Infection.
Dustin LB
Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
[TBL] [Abstract][Full Text] [Related]
46. [Association between chronicity of HBV infection and host immunity].
Shang XB; Zhao Q; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):474-7. PubMed ID: 27465957
[TBL] [Abstract][Full Text] [Related]
47. Phenotypic features of innate and adaptive immunity in patients with chronic hepatitis C and end-stage renal disease.
Barbosa KV; Teixeira R; Bassetti-Soares E; de Souza AF; Penido JM; Teixeira-Carvalho A; Martins-Filho OA
Liver Int; 2013 Oct; 33(9):1349-56. PubMed ID: 23692646
[TBL] [Abstract][Full Text] [Related]
48. Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.
Lee JW; Kim W; Kwon EK; Kim Y; Shin HM; Kim DH; Min CK; Choi JY; Lee WW; Choi MS; Kim BG; Cho NH
PLoS One; 2017; 12(6):e0179094. PubMed ID: 28614389
[TBL] [Abstract][Full Text] [Related]
49. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.
Li X; Liu X; Tian L; Chen Y
Clin Rev Allergy Immunol; 2016 Feb; 50(1):41-54. PubMed ID: 25480494
[TBL] [Abstract][Full Text] [Related]
50. Hepatic CD206-positive macrophages express amphiregulin to promote the immunosuppressive activity of regulatory T cells in HBV infection.
Dai K; Huang L; Sun X; Yang L; Gong Z
J Leukoc Biol; 2015 Dec; 98(6):1071-80. PubMed ID: 26216935
[TBL] [Abstract][Full Text] [Related]
51. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
52. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
Wang FS; Zhang Z
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
[TBL] [Abstract][Full Text] [Related]
53. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
54. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection.
Zhang Z; Zhang JY; Wang LF; Wang FS
J Gastroenterol Hepatol; 2012 Feb; 27(2):223-30. PubMed ID: 22004062
[TBL] [Abstract][Full Text] [Related]
55. Immunopathogenesis of hepatitis B virus infection.
Chang JJ; Lewin SR
Immunol Cell Biol; 2007 Jan; 85(1):16-23. PubMed ID: 17130898
[TBL] [Abstract][Full Text] [Related]
56. Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response?
Koh S; Bertoletti A
Med Microbiol Immunol; 2015 Feb; 204(1):87-94. PubMed ID: 25511870
[TBL] [Abstract][Full Text] [Related]
57. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
58. [Parameters of innate immunity in clinically manifested and subclinic forms of infections caused by hepatitis B and C viruses].
Gulieva AA; Mamedov MK; Dadasheva AE; Safarova SM
Georgian Med News; 2010 Nov; (188):29-33. PubMed ID: 21178200
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
Lan P; Zhang C; Han Q; Zhang J; Tian Z
Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
[TBL] [Abstract][Full Text] [Related]
60. Immunopathogenesis of chronic hepatitis C virus infection.
Li DY; Schwarz KB
J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):260-7. PubMed ID: 12352510
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
